Vision
Promoting scientific collaboration and advancement in the treatment of multiple myeloma and plasma cell disorders; thereby ensuring easy and equitable access to evidence-based knowledge and health care services.
Mission
USMIRC’s mission is to promote collaboration and development of clinical trials and advance treatment options for patients with multiple myeloma and plasma cell disorders. The goal is to empower and engage hematologists, oncologists, pharmacists, nurses, postgraduate students, and myeloma patients across the United States in the discussion and treatment of multiple myeloma and plasma cell disorders.
